Medical Devices
Metabolic Biomarkers Of Autism
WARF: P09343US02
Inventors: Gabriela Cezar, Alan Smith
The Invention
This invention provides methods and biomarkers for diagnosing autism by identifying cellular metabolites differentially produced in autistic patient samples versus non-autistic controls. Methods for identifying a unique profile of metabolites present of secreted in brain tissue, cerebrospinal fluid, plasma, or biofluids of autistic samples are described herein. The individual metabolites or a pattern of secreted metabolites provide metabolic signatures of autism, which can be used to provide a diagnosis thereof.
Additional Information
Related Intellectual Property
Tech Fields
For current licensing status, please contact Andy DeTienne at [javascript protected email address] or 608-960-9857